Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MEETINGS - Molecular & Genetic Diagnostics: Profiting from Novel Diagnostics that Assess Disease Risk, Disease Presence & Treatment Response (UK) October 1999:

This article was originally published in Clinica

Executive Summary

IBC Conferences will hold a meeting on Molecular & Genetic Diagnostics: Profiting from Novel Diagnostics that Assess Disease Risk, Disease Presence & Treatment Response in London on October 4-5. Dr Uwe Bicker, executive chairman and director of Dade Behring and president of the European Diagnostic Manufacturers Association (EDMA), will present the keynote speech on growth & shift in the diagnostics industry. Representatives from companies including Roche Molecular Systems, Shield Diagnostics and Nycomed Amersham Imaging will discuss some of the latest developments in this field. For more details contact IBC in the UK. Tel: +44 20 7453 5496. Fax: +44 20 7636 6858. Website: www.ibc-uk.com/it1135

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079171

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel